Novocure (NVCR) Tops Q2 EPS by 2c

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.36), $0.02 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $158.8 million versus the consensus estimate of $153.33 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Reduce (3)
• Axis Capital Limited Upgrades Infosys Ltd. (INFO:IN) (INFY) to Buy (1)